ATE310533T1 - Zusammensetzungen mit stabilem faktor viii - Google Patents

Zusammensetzungen mit stabilem faktor viii

Info

Publication number
ATE310533T1
ATE310533T1 AT00948452T AT00948452T ATE310533T1 AT E310533 T1 ATE310533 T1 AT E310533T1 AT 00948452 T AT00948452 T AT 00948452T AT 00948452 T AT00948452 T AT 00948452T AT E310533 T1 ATE310533 T1 AT E310533T1
Authority
AT
Austria
Prior art keywords
compositions
factor viii
stable factor
stable
viii
Prior art date
Application number
AT00948452T
Other languages
English (en)
Inventor
Marianne Mikaelsson
Helena Sandberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27354553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE310533(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9902685A external-priority patent/SE9902685D0/xx
Priority claimed from SE0001743A external-priority patent/SE0001743D0/xx
Application filed filed Critical
Application granted granted Critical
Publication of ATE310533T1 publication Critical patent/ATE310533T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT00948452T 1999-07-13 2000-07-07 Zusammensetzungen mit stabilem faktor viii ATE310533T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9902685A SE9902685D0 (sv) 1999-07-13 1999-07-13 Stable protein compositions
US14682899P 1999-08-02 1999-08-02
SE0001743A SE0001743D0 (sv) 2000-05-11 2000-05-11 Stable protein compositions II
PCT/SE2000/001454 WO2001003726A1 (en) 1999-07-13 2000-07-07 Stable factor viii compositions

Publications (1)

Publication Number Publication Date
ATE310533T1 true ATE310533T1 (de) 2005-12-15

Family

ID=27354553

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00948452T ATE310533T1 (de) 1999-07-13 2000-07-07 Zusammensetzungen mit stabilem faktor viii

Country Status (14)

Country Link
US (1) US6599724B1 (de)
EP (1) EP1194161B1 (de)
JP (1) JP4674021B2 (de)
AR (1) AR024735A1 (de)
AT (1) ATE310533T1 (de)
AU (1) AU780415B2 (de)
CA (1) CA2378751C (de)
CY (1) CY1104986T1 (de)
DE (1) DE60024268T2 (de)
DK (1) DK1194161T3 (de)
ES (1) ES2252028T3 (de)
NO (1) NO330048B1 (de)
NZ (1) NZ516400A (de)
WO (1) WO2001003726A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU777972B2 (en) 1999-02-22 2004-11-04 Baxalta GmbH Novel albumin-free factor VIII formulations
WO2003055512A1 (en) * 2001-12-21 2003-07-10 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
KR20040065278A (ko) * 2001-12-21 2004-07-21 노보 노르디스크 에이/에스 변경된 인자 ⅶ 폴리펩티드의 액체 조성물
GB0202633D0 (en) * 2002-02-05 2002-03-20 Delta Biotechnology Ltd Stabilization of protein preparations
GB0207092D0 (en) * 2002-03-26 2002-05-08 Sod Conseils Rech Applic Stable pharmaceutical composition containing factor VIII
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
AU2003240438A1 (en) 2002-06-21 2004-01-06 Novo Nordisk A/S Stabilised solid compositions of factor vii polypeptides
ATE513283T1 (de) † 2002-12-27 2011-07-15 Nippon Kinsen Kikai Kk Optische messeinrichtung zur erkennung optischer merkmale von wertpapieren
RU2005132164A (ru) * 2003-03-18 2006-06-10 Ново Нордиск Хелт Кэр Аг (Ch) Жидкие, водные фармацевтические композиции полипептидов фактора vii
US7897734B2 (en) * 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
MXPA05012476A (es) * 2003-05-23 2006-02-22 Novo Nordisk Healthcare Ag Estabilizacion de proteina en solucion.
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
US7498024B2 (en) 2003-06-03 2009-03-03 Cell Genesys, Inc. Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
ATE547114T1 (de) * 2003-06-25 2012-03-15 Novo Nordisk Healthcare Ag Flüssige zusammensetzungen von factor vii polypeptiden
ATE446768T1 (de) * 2003-07-01 2009-11-15 Novo Nordisk Healthcare Ag Flüssige wässrige pharmazeutische zusammnesetzung von factor vii polypeptiden
KR101293503B1 (ko) 2003-08-14 2013-08-07 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ｖｉｉ 폴리펩티드의 액상 수성 약학적 조성물
ES2229931B1 (es) * 2003-10-03 2006-01-16 Grifols, S.A. Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
DE602004026474D1 (de) * 2003-12-03 2010-05-20 Univ Rochester Rekombinanter faktor viii mit erhöhter spezifischer aktivität
BRPI0417721B8 (pt) * 2003-12-19 2021-05-25 Novo Nordisk Healthcare Ag kit contendo um medicamento farmacêutico, método para preparar uma formulação líquida de um fator recombinante viia, composição e métodos para preparar as composições
US7422875B2 (en) 2004-07-20 2008-09-09 Board Of Regents Of The University Of Nebraska Compositions and methods for increasing protein production
EP1919498A2 (de) * 2005-08-26 2008-05-14 Maxygen Holdings Ltd. Flüssige faktor-vii-zusammensetzung
FR2908892B1 (fr) * 2006-11-21 2009-02-20 Hyphen Biomed Soc Par Actions Procede pour le dosage chromogenique de l'activite du facteur viii:c et necessaire de dosage chromogenique de l'activite du facteur viii:c,dans les plasmas ou les fractions therapeutiques
EP2209908B1 (de) * 2007-11-01 2014-09-03 University Of Rochester Rekombinanter faktor viii mit erhöhter stabilität
MX343269B (es) 2007-12-27 2016-10-31 Baxter Int Procesos de cultivo celular.
JP5779780B2 (ja) 2008-11-07 2015-09-16 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 第ｖｉｉｉ因子製剤
GB0915481D0 (en) 2009-09-04 2009-10-07 Arecor Ltd Stable manufacture of factor V111
GB0915480D0 (en) 2009-09-04 2009-10-07 Arecor Ltd Stable formulation of factor viii
MY165089A (en) 2010-11-05 2018-02-28 Baxalta Inc A new variant of antihemophilic factor viii having increased specific activity
JP6178786B2 (ja) * 2011-05-13 2017-08-09 オクタファルマ・アーゲー 組換えｆｖｉｉｉの生産において真核細胞の生産性を向上させる方法
KR20140084208A (ko) 2011-10-18 2014-07-04 시에스엘 리미티드 정제된 인자 ｖｉｉｉ의 재구성 후의 안정성을 향상시키는 방법
CN106413741A (zh) * 2014-04-01 2017-02-15 爱德技术生物科学有限公司 含低糖‑甘氨酸的稳定因子viii制剂
KR20160146763A (ko) * 2014-04-01 2016-12-21 어드밴텍 바이오사이언스 파마큐티카 엘티디에이 부형제로서 칼슘이 첨가되지 않은 factor viii의 안정화

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607927B2 (en) 1986-06-24 1991-03-21 Nordisk Gentofte A/S A process for producing a coagulation active complex of factor viii fragments
JP3905921B2 (ja) 1992-10-02 2007-04-18 ジェネティクス インスチチュート リミテッド ライアビリティー カンパニー 凝固第▲ｖｉｉｉ▼因子を含む組成物及びその製造方法並びに安定剤としての界面活性剤の使用方法
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
WO1995003332A1 (en) * 1993-07-23 1995-02-02 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
DE69737455T2 (de) * 1996-10-11 2007-12-06 Invitrogen Corp., Carlsbad Definierte systeme zur kultivierung epithelialer zellen und anwendung derselben
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium

Also Published As

Publication number Publication date
DE60024268D1 (de) 2005-12-29
NO20020120L (no) 2002-02-28
JP2003504345A (ja) 2003-02-04
CA2378751C (en) 2012-11-06
NZ516400A (en) 2004-02-27
DE60024268T2 (de) 2006-08-03
CY1104986T1 (el) 2009-11-04
AR024735A1 (es) 2002-10-23
AU780415B2 (en) 2005-03-17
AU6193300A (en) 2001-01-30
NO330048B1 (no) 2011-02-07
WO2001003726A1 (en) 2001-01-18
NO20020120D0 (no) 2002-01-10
EP1194161A1 (de) 2002-04-10
EP1194161B1 (de) 2005-11-23
US6599724B1 (en) 2003-07-29
DK1194161T3 (da) 2006-02-13
ES2252028T3 (es) 2006-05-16
JP4674021B2 (ja) 2011-04-20
CA2378751A1 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
ATE310533T1 (de) Zusammensetzungen mit stabilem faktor viii
IS6120A (is) Lyfjablanda
DE60014179D1 (de) Tintenzusammensetzungen
AR023440A1 (es) Composiciones antitranspirantes
DE69921991D1 (de) Harzzusammensetzungen
DE60018597D1 (de) Antistatische zusammensetzung
DE50006571D1 (de) Dosiervorrichtung
DE60043447D1 (de) Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid
NO20004497L (no) Modifisert faktor VIII
ITMI991754A0 (it) Composizioni cosmetiche
DE60007694D1 (de) Beschichtungszusammensetzung
FI990170A0 (fi) Maksunosoitus
DE60021018D1 (de) Polymerzusammensetzungen
ID29785A (id) Komposisi-komposisi sampo
DK200100181U3 (da) Leveringsboks
DE60007731D1 (de) Schweisshemmende zusammensetzungen
DE60015460D1 (de) Polymerzusammensetzungen
DE69943245D1 (de) Gaserzeugende zusammensetzung
DE60045012D1 (de) Filmbildende zusammensetzung mit oktylbenzoat
DE60013905D1 (de) Lichtstreuende harzzusammensetzung
ATE286174T1 (de) Beschichtungzusammensetzung
DE60041389D1 (de) Harzzusammensetzung
DE60004363D1 (de) Faktor viia inhibitore
ID26541A (id) Komposisi resin poliolefin
DE60023481D1 (de) Injizierbare zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1194161

Country of ref document: EP